Publicaciones en colaboración con investigadores/as de University of Texas Southwestern Medical Center (1)

2019

  1. A Phase II Trial of Lutikizumab, an Anti–Interleukin-1α/β Dual Variable Domain Immunoglobulin, in Knee Osteoarthritis Patients With Synovitis

    Arthritis and Rheumatology, Vol. 71, Núm. 7, pp. 1056-1069